Summary

for people ages 18 years and up (full criteria)
at San Francisco, California
study started
estimated completion
Lizabeth A Goldstein, PhD

Description

Summary

The purpose of this study is to determine whether a behavioral sleep treatment improves functioning and sleep in Veterans with posttraumatic stress disorder (PTSD).

Official Title

Improving Sleep and Functioning in Veterans With Posttraumatic Stress Disorder

Details

This study is a randomized controlled trial of a behavioral sleep treatment improves functioning and sleep in Veterans with PTSD, sleep apnea, and insomnia. The treatment is delivered partially in person and partially via telehealth (video to home). The primary outcome for this study is quality of life. Other outcomes include sleep-related functioning, PTSD symptom severity, insomnia symptom severity, and CPAP adherence. Participants will also provide treatment feedback to aid in assessment of treatment feasibility and acceptability.

Keywords

Sleep Apnea Syndromes Insomnia Disorder Stress Disorders, Post-Traumatic Sleep Apnea, Central Sleep Apnea, Obstructive Sleep Initiation and Maintenance Disorders Insomnia PTSD Veterans Apnea Disease Stress Disorders, Traumatic Apnea and Insomnia Relief (AIR) Sleep Education (SE)

Eligibility

You can join if…

Open to people ages 18 years and up

  • Veterans diagnosed with sleep apnea with Apnea Hypopnea Index of at least 5 via sleep study at San Francisco VA Healthcare System and recommended for PAP therapy
  • Meet DSM-5 Criteria for Posttraumatic Stress Disorder
  • Meet DSM-5 Criteria for Insomnia Disorder
  • Willing to attend all treatment and assessment appointments
  • English literacy and cognition sufficient to participate in treatment and

You CAN'T join if...

  • Psychosis or manic episode in last 5 years
  • Substance use disorder in past 6 months
  • Started or ended psychotherapy for a sleep disorder or mental health diagnosis within the last 1 month and do not plan to discontinue this treatment during the trial
  • Started or ended an antidepressant, anxiolytic, or sleep medication with the last 1 month and do not plan to discontinue this treatment during the trial
  • Prominent suicidal or homicidal ideation requiring alternative treatment for patient safety
  • Untreated sleep disorders that may interfere with successful treatment (up to discretion of Principal Investigator)
  • Having travel of personal plans that would disrupt regular treatment engagement (up to discretion of Principal Investigator)
  • Working night shifts or rotating shifts that include night shifts
  • Lack of stable housing
  • Pregnancy

Location

  • San Francisco VA Medical Center, San Francisco, CA not yet accepting patients
    San Francisco California 94121 United States

Lead Scientist

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
VA Office of Research and Development
ID
NCT04007796
Phase
Phase 2
Study Type
Interventional
Last Updated